Optimizing Downstream Chromatography: Reducing Costs And Improving Efficiency

In the competitive landscape of biopharmaceutical manufacturing, downstream chromatography often accounts for up to 80% of total production costs. Achieving operational efficiency requires moving beyond legacy methodologies toward process intensification. By leveraging modern resin technologies characterized by rapid mass transfer and high dynamic binding capacities, facilities can successfully implement reduced bed heights and increased flow rates. These adjustments allow for more cycles per hour, significantly boosting productivity while reducing resin volume and buffer consumption.

Furthermore, addressing host cell protein (HCP) challenges is critical for product safety. Utilizing novel resins that enable elution under milder, higher-pH conditions helps mitigate protein aggregation and enhances impurity clearance.

Explore these strategies for optimizing your purification workflow and reducing environmental impact in the detailed case studies and technical insights below.